# Statistical Aspects of the Design, Analysis, and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/statistical-aspects-of-the-design-analysis-and-interpretation-of-chronic-rodent-carcinogenicity-studies-of-pharmaceuticals/f8ef1e83-587f-48eb-8b42-d6a9e1d3b934

> FDA guidance document: Statistical Aspects of the Design, Analysis, and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals. Issue date: May 08, 2001. Get complete insights and analysis.

---

## Details

- Title: Statistical Aspects of the Design, Analysis, and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2001-05-08
- Last Changed: 2021-01-26
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2001-D-0043">FDA-2001-D-0043</a>

## Related Documents

- [Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action](https://www.globalkeysolutions.net/guidances/guidance-document/bioavailability-and-bioequivalence-studies-for-nasal-aerosols-and-nasal-sprays-for-local-action/c75f03a9-fe74-43cb-90de-ab8a4cbbd770)
- [Evaluation of Therapeutic Equivalence](https://www.globalkeysolutions.net/guidances/guidance-document/evaluation-of-therapeutic-equivalence/cd67148c-495a-4ce8-be79-e37f4769b3ae)
- [Pharmacokinetics in Pregnancy — Study Design, Data Analysis, and Impact on Dosing and Labeling](https://www.globalkeysolutions.net/guidances/guidance-document/pharmacokinetics-in-pregnancy-study-design-data-analysis-and-impact-on-dosing-and-labeling/08e99d11-48f5-4d96-a72c-c66cde9d04ca)